UnicoCell

  • About
  • Cell Therapy
  • Products & services
  • News
  • Contact
  • 中文 / EN

Home > News > All News

News

    • Press Release
    • Events
All News
  • 2022-06-27 2022.7.28-31 Visit UnicoCell @2022 Bio Asia-Taiwan Exhibit

  • 2022-06-23 2022.6.23 UnicoCell and Tzu-Chi Hospital Ophthalmology Research Center collaborate to Open New Horizons of "Vision"

  • 2022-06-17 2022.6.17 Study The Mechanism of Action of ELIXCYTE, an Allogenic Stem Cell Product, on Osteoarthritis has been published in Cytotherapy

  • 2022-06-08 2022.6.8 UnicoCell has received approval of patent case filed with the US Patent and Trademark Office for "UnicoVial Cell Storage Tube"

  • 2022-04-13 2022.4.12 Phase I clinical trial results of ELIXCYTE for chronic kidney disease has been published in Journal of Cellular and Molecular Medicine

  • 2022-03-15 2022.3.15 UnicoCell has received approval for application of "Human Organ Storage Facility" by the Ministry of Health and Welfare.

  • 2022-03-14 2022.3.14 UnicoCell has received approval of patent case filed with the South Korea Patent Office for "UnicoVial Cell Storage Container"

  • 2022-03-08 2022.3.7 The Ministry of Health and Welfare approved the application for the "Cell Process Unit" in cooperation with the Jingmei Hospital.

  • 2022-03-03 2022.3.3 UnicoCell has received approval of patent case filed with the China Patent Office for "UnicoVial Cell Storage Container"

  • 2022-01-26 2022.1.25 The Ministry of Health and Welfare approved the application for the "Cell Process Unit" in cooperation with the Tri-Service General Hospital.

  • «
  • 1
  • 2
  • 3
  • 4
  • 5
  • »
4 page / total 5
向榮生醫科技

11494 台北市內湖區民權東路六段13之20號5樓

Tel:886-2-2792-2699 FAX:886-2-2792-7890

E-Mail : info@unicocell.com

LinkedIn Facebook Line
Copyright © 2018-2025 向榮生醫科技股份有限公司